Physician

David Liska, M.D.

According to 2025 Medicare claims, David Liska, M.D. (NPI: 1902063589) practices colorectal surgery (formerly proctology) in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44195-0001. Liska is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Liska's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 113 traditional Medicare patients, billed 261 HCPCS/CPT codes, and received $36,069 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 182 prescription claims across 75 beneficiaries totaling $3,857 in drug costs, led by Loperamide (Loperamide Hcl). DME data shows 737 claims. Open Payments data shows 5 records totaling $885. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $27,581 and ending at $36,069. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,267 and ending at $3,857. For DME billing, reported payments moved sharply higher in recent years, from $155 to $1,451.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	87	134	$27,581
2016	114	181	$40,406
2017	67	134	$27,852
2018	81	195	$41,897
2019	110	281	$61,284
2020	91	182	$37,737
2021	123	285	$49,970
2022	101	253	$46,146
2023	117	320	$58,162
2024	113	261	$36,069

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	54	84	$2,267
2016	59	104	$2,673
2017	46	95	$4,893
2018	53	96	$1,198
2019	55	144	$3,992
2020	46	139	$8,253
2021	66	149	$13,935
2022	56	128	$10,119
2023	83	207	$11,317
2024	75	182	$3,857

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	25	$1,616
2017	N/R	N/R	N/R
2018	N/R	48	$4,683
2019	24	157	$11,402
2020	12	126	$11,743
2021	84	437	$35,859
2022	63	510	$37,163
2023	68	565	$45,543
2024	119	737	$64,819

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	16	16	$137
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	30	35	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	27	33	$68
45330	Diagnostic exam of lower portion of large bowel using a flexible endoscope	12	15	$36
46600	Diagnostic exam of anus using an endoscope	14	20	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Loperamide	Loperamide Hcl	31	1,159	$1,331
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	739	$912
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	24	53	$415
Neomycin Sulfate	Neomycin Sulfate	34	42	$127
Metronidazole	Metronidazole	31	46	$48

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	18	89	$13,612
A5057	Ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), each	N	13	40	$13,128
A4407	Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each	N	11	51	$9,165
A4362	Skin barrier; solid, 4 x 4 or equivalent; each	N	13	64	$5,495
A4425	Ostomy pouch, drainable; for use on barrier with non-locking flange, with filter (2 piece system), each	N	N/R	39	$2,793

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$885	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Liska, M.D.?

Tedicare shows public-source Medicare data for David Liska, M.D. (NPI 1902063589), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Liska, M.D. have ACO affiliation data?

David Liska, M.D. is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to David Liska, M.D.?

David Liska, M.D. is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does David Liska, M.D. have Open Payments data?

David Liska, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.